Skip to main navigation Skip to search Skip to main content

The Yin and Yang aspects of IL-27 in induction of cancer-specific T-cell responses and immunotherapy

  • Ming Song Li
  • , Zhenzhen Liu
  • , Jin Qing Liu
  • , Xiaotong Zhu
  • , Zhihao Liu
  • , Xue Feng Bai

Research output: Contribution to journal › Review article › peer-review

Abstract

Accumulating evidences from animal studies have indicated that both endogenous and exogenous IL-27, an IL-12 family of cytokine, can increase antitumor T-cell activities and inhibit tumor growth. IL-27 can modulate Treg responses, and program effector T cells into a unique T-effector stem cell (TSEC) phenotype, which enhances T-cell survival in the tumor microenvironment. However, animal studies also suggest that IL-27 induces molecular pathways such as IL-10, PD-L1 and CD39, which may downregulate tumor-specific T-cell responses. In this review paper, we will discuss the Yin and Yang aspects of IL-27 in the induction of tumor-specific T-cell responses, and the potential impacts of these functions of IL-27 in the design of cancer immunotherapy.

Original languageEnglish
Pages (from-to)191-200
Number of pages10
JournalImmunotherapy
Volume7
Issue number2
DOIs
StatePublished - Feb 1 2015

Keywords

  • IL-12
  • IL-27
  • T-effector stem cells
  • cancer immunotherapy
  • regulatory T cells

Fingerprint

Dive into the research topics of 'The Yin and Yang aspects of IL-27 in induction of cancer-specific T-cell responses and immunotherapy'. Together they form a unique fingerprint.

Cite this